Related Experiment Videos

Benign reversible muscle cytochrome c oxidase deficiency: a second case

Neurology
|January 1, 1987
PubMed

Insights

This case study highlights a benign infantile myopathy caused by reversible cytochrome c oxidase (COX) deficiency. Early symptoms improved, demonstrating the condition

Area of Science:

  • Biochemistry
  • Pediatric Neurology
  • Mitochondrial Diseases

Background:

  • Infantile myopathies can present with severe symptoms like generalized weakness and lactic acidosis.
  • Cytochrome c oxidase (COX) deficiency is a known cause of mitochondrial myopathies.

Observation:

  • A 6-week-old infant experienced generalized weakness, lactic acidosis, and required assisted ventilation.
  • Muscle biopsies revealed mitochondrial, lipid, and glycogen accumulation with significantly reduced COX activity.
  • Clinical improvement and resolution of lactic acidosis occurred by 6 months, with ventilation discontinued at 15 months.

Findings:

  • Initial COX activity was 11% of control, increasing to 57% by 11 months, indicating reversible deficiency.
  • Immunocytochemistry confirmed the presence of COX enzyme protein, despite low activity.
  • Severe fibrosis noted in later biopsies may correlate with slower clinical recovery.

Implications:

  • This case supports the existence of benign infantile myopathy linked to reversible COX deficiency.
  • Understanding the reversibility of COX deficiency is crucial for diagnosing and managing pediatric mitochondrial disorders.
  • Fibrosis progression may impact long-term prognosis in mitochondrial myopathies.

Related Concept Videos